Matt Murphy
Manager of Investor Relations
Replay available
Cara Therapeutics, Inc. (CARA) Q1 2023 Earnings Call
Cara Therapeutics, Inc. (NASDAQ: CARA) Q1 2023 earnings conference call, held 2023-05-15. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Chris Posner
Chief Executive Officer
Ryan Maynard
Chief Financial Officer
Joseph Stringer
Analyst, Needham & Company
Annabel Simimi
Analyst, Stiefel
Dr. Joanna Consalves
Chief Medical Officer
Jason Gerberry
Analyst, Bank of America Securities
Sumant Kulkarni
Analyst, Canaccord Genuity
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Tvardi Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.169 -- 00:00:04.752 Good afternoon. My name is Lateef, and I will be your conference facilitator. 00:00:04.752 -- 00:00:09.915 I would like to welcome everyone to the CARA Therapeutics first quarter financial results 00:00:09.915 -- 00:00:15.178 and update conference call. All lines have been placed on mute to avoid any background 00:00:15.178 -- 00:00:20.542 noise. After the speaker's remarks, there will be a question and answer session. 00:00:20.542 -- 00:00:25.105 If you would like to ask a question during this time, simply press star and the number 00:00:25.105 -- 00:00:28.228 1-1 on your telephone keypad. 00:00:28.228 -- 00:00:33.070 To remove your name from the queue, simply press star and the number 11 00:00:33.070 -- 00:00:36.771 again. Please be advised that this call is being recorded. 00:00:36.771 -- 00:00:42.173 I would now like to introduce Matt Murphy, CARA's Manager of Investor Relations. 00:00:42.173 -- 00:00:46.074 Mr. Murphy, you may begin your call. 00:00:46.595 -- 00:00:49.416 Thank you, Operator, and good afternoon. 00:00:49.416 -- 00:00:54.058 After market closed today, CARA issued a news release announcing the company's financial 00:00:54.058 -- 00:00:58.509 and operating results for the first quarter of 2023. 00:00:58.669 -- 00:01:03.612 Copies of this news release and the associated SEC filing can be found in the investor 00:01:03.612 -- 00:01:07.593 section of our website at www.caratherapeutics.com. 00:01:09.035 -- 00:01:13.477 Before we begin, let me remind you that during the course of this conference call, we 00:01:13.477 -- 00:01:18.179 will be making certain forward-looking statements about CARA and our programs based on 00:01:18.179 -- 00:01:21.521 management's current plans and expectations. 00:01:21.521 -- 00:01:25.5...